Zai Lab
Brent Eberle is an experienced Talent Acquisition professional currently serving as the Talent Acquisition Leader at Jasper Therapeutics since June 2024. Eberle has also been an HR Director, Talent Acquisition Consultant at Zai Lab since August 2021 and has been leading recruitment initiatives as a Senior Contract Recruiter and Founder of BRecruiting, Inc. since February 2008. Throughout a diverse career, Eberle has held various consulting roles in talent identification and engagement at organizations such as Five Prime Therapeutics, Tricida, Inc., and Actelion Pharmaceuticals, focusing on innovative biopharmaceutical solutions and staffing strategies. Eberle holds a Bachelor of Science degree from the University of Nevada-Las Vegas.
This person is not in any teams
This person is not in any offices
Zai Lab
5 followers
Zai Lab Ltd is a biopharmaceutical company. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the fields of oncology, autoimmune and infectious diseases. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include three drug candidates with greater China rights and three drug candidates with global rights. The greater China rights drug candidates include Niraparib (ZL-2306), Omadacycline (ZL-2401) and ZL-2301. The global rights drug candidates include Fugan (ZL-3101), ZL-2302 and ZL-1101.